These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A complex interplay of genetic and epigenetic events leads to abnormal expression of the DUX4 gene in facioscapulohumeral muscular dystrophy. Gatica LV; Rosa AL Neuromuscul Disord; 2016 Dec; 26(12):844-852. PubMed ID: 27816329 [TBL] [Abstract][Full Text] [Related]
7. Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD). Ansseau E; Vanderplanck C; Wauters A; Harper SQ; Coppée F; Belayew A Genes (Basel); 2017 Mar; 8(3):. PubMed ID: 28273791 [TBL] [Abstract][Full Text] [Related]
8. Single-cell RNA sequencing in facioscapulohumeral muscular dystrophy disease etiology and development. van den Heuvel A; Mahfouz A; Kloet SL; Balog J; van Engelen BGM; Tawil R; Tapscott SJ; van der Maarel SM Hum Mol Genet; 2019 Apr; 28(7):1064-1075. PubMed ID: 30445587 [TBL] [Abstract][Full Text] [Related]
9. PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle. Banerji CRS; Panamarova M; Hebaishi H; White RB; Relaix F; Severini S; Zammit PS Nat Commun; 2017 Dec; 8(1):2152. PubMed ID: 29255294 [TBL] [Abstract][Full Text] [Related]
10. Targeting mRNA for the treatment of facioscapulohumeral muscular dystrophy. Bao B; Maruyama R; Yokota T Intractable Rare Dis Res; 2016 Aug; 5(3):168-76. PubMed ID: 27672539 [TBL] [Abstract][Full Text] [Related]
11. Design of AAV Vectors for Delivery of RNAi. Borel F; Mueller C Methods Mol Biol; 2019; 1950():3-18. PubMed ID: 30783965 [TBL] [Abstract][Full Text] [Related]
12. Antisense targeting of 3' end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for facioscapulohumeral dystrophy: a new gene-silencing approach. Marsollier AC; Ciszewski L; Mariot V; Popplewell L; Voit T; Dickson G; Dumonceaux J Hum Mol Genet; 2016 Apr; 25(8):1468-78. PubMed ID: 26787513 [TBL] [Abstract][Full Text] [Related]